quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

'Trump Account' newborns could have $1.9M by 28, Treasury Dept. says. Here's what's required to get that much

View original at finance.yahoo.com
'Trump Account' newborns could have $1.9M by 28, Treasury Dept. says. Here's what's required to get that much Shutterstock Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • To reach $1.9 million by age 28, parents would need to max out accounts by investing maximum every year until child's 17th birthday, starting at $5,000 per year adjusted for inflation

    80% confidence
  • Trump accounts provide a more limited and restricted tax benefit than existing saving incentives, such as 529 accounts

    80% confidence
  • Moby's individual stock picks have outperformed the S&P 500 index returns by an average of 11.95% per year over the last four years

    80% confidence
  • With no additional contributions beyond initial $1,000, accounts could turn into between $3,000 and $13,800 over 18 years depending on performance

    80% confidence
  • Annual costs of raising a small child average $29,419 today, a 35.7% increase from 2023 survey

    80% confidence
  • Trump accounts could grow to $1.9 million over 28 years

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
'Trump Account' newborns could have $1.9M by 28, Treasury Dept. says. Here's what's required to get that much — Source | Via News | pt.VIA.NEWS